1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 2: 
Thrombectomy procedure metrics: clinical and radiologic outcomes
Thrombectomies in Patients with COVID-19 (n = 13)
Anesthesia method (No.) (%)
 General anesthesia9 (69.2%)
 Conscious sedation4 (30.7%)
Initial treatment approach (No.) (%)
 Stent retriever4 (30.7%)
 ADAPT technique6 (46.1%)
 Combined distal aspiration and stent retriever3 (23.0%)
Timing of intervention (median) (IQR)( min)
 Femoral puncture to recanalization34.5 (23–45)
 Symptom onset to recanalization298.5 (261–324)
Angiographic outcome (No.) (%)
 TICI 2b–310 (76.9%)
 TICI 2c–39 (69.2%)
 TICI 37 (53.8%)
Procedural complications (No.) (%)
 Neurologic0 (0%)
 Non-neurologic (femoral artery occlusion)1 (7.6%)
Imaging outcome (No). (%)
 All hemorrhagic transformation3 (23.0%)
 Symptomatic ICH0 (0%)
 HI1–HI22 (15.3%)
 PH 11 (7.6%)
 PH 20 (0%)
Clinical outcome
 In-hospital mortality (No.) (%)2 (15.3%)
 Last available NIHSS (median) (IQR)a5 (0.5–12.5)
 NIHSS drop (median) (IQR)a2 (0.5–5)
  • Note:—ADAPT indicates direct aspiration first pass technique; ICH, intracerebral hemorrhage; PH, parenchymal hematoma; HI, petechial hemorrhage.
  • ↵a n = 10 (excluding 2 deceased patients).